Provident Trust Company’s Pfizer PFE Stock Holding History

Provident Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,035	Closed	-$206K	–	50
2019 Q3	$206K	Buy	+6,035	New	+$219K	0.01%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Provident Trust Company's PFE Position: Q4 2019 in Review

Provident Trust Company sold out of Pfizer (PFE) in Q4 2019, closing a stake of 6,035 shares — an estimated $206K sold.

Provident Trust Company first reported a position in PFE in Q3 2019 and held it in 1 quarter. The position peaked at $206K in Q3 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

Provident Trust Company reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
Provident Trust Company sold 6,035 Pfizer shares in Q4 2019, an estimated $206K.
Provident Trust Company first reported a position in Pfizer in Q3 2019 and held it in 1 quarter.
Provident Trust Company's Pfizer position peaked at $206K in Q3 2019.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Provident Trust Company's 13F filing for Q4 2019, filed 31 Jan 2020.